ReviewFrontiers in oncology2021

Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches.

David W Cescon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.